| 产品名称: | Influenza A virus (H3N2) |
|---|---|
| 商品货号: | TS213811 |
| Classification: | Orthomyxoviridae, Alphainfluenzavirus |
| Agent: | Influenza A virus (H3N2) |
| Strain: | A/California/2/2014 |
| Applications: | Respiratory research Vaccine development |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | frozen 0.5 mL per vial |
| Storage Conditions: | -70°C or colder |
| Images: | |
| Effect on Host: | CPE, refractile rounding and sloughing |
| Recommended Host: | MDCK cells (ATCC® CCL-34™) |
| Growth Conditions: | Temperature: 35°C Recommendations for Infection: Plate cells 18-24 hours prior to infection and infect when cultures are 80-90% confluent. Remove medium and inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g. 0.1 to 0.01). Adsorb 1-2 hours at 35°C in a humidified 5% CO2 atmosphere. End adsorption by adding virus growth medium. Incubation: 2-3 days at 35°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 75% of the monolayer. |
| Name of Depositor: | D Wadford, California Department of Public Health |
| Source: | Isolated from a human in California, USA on January 16, 2014. |
| Year of Origin: | 2014 |